Cardinal Health, Inc. (LON:0HTG)
202.48
-0.25 (-0.12%)
At close: Jan 9, 2026
Cardinal Health Market Cap
Cardinal Health has a market cap or net worth of 35.64 billion as of January 9, 2026. Its market cap has increased by 55.74% in one year.
Market Cap
35.64B
Enterprise Value
39.07B
Revenue
174.31B
Ranking
n/a
PE Ratio
30.04
Stock Price
202.48
Market Cap Chart
Since October 18, 1993, Cardinal Health's market cap has increased from 708.13M to 35.64B, an increase of 4,933.46%. That is a compound annual growth rate of 12.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 35.64B | -1.75% |
| Dec 31, 2025 | 36.28B | 58.67% |
| Dec 31, 2024 | 22.86B | 17.22% |
| Dec 29, 2023 | 19.50B | 16.63% |
| Dec 30, 2022 | 16.72B | 56.07% |
| Dec 31, 2021 | 10.72B | -6.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.48B |
| GSK plc | 75.67B |
| Haleon | 32.73B |
| Smith & Nephew | 10.69B |
| Convatec Group | 4.80B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.70B |